索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]沈迎,张瑞岩,丁风华,等.糖尿病与冠状动脉微血管性心绞痛[J].国际心血管病杂志,2016,05:257-260.
点击复制

糖尿病与冠状动脉微血管性心绞痛(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年05期
页码:
257-260
栏目:
综述
出版日期:
2016-09-20

文章信息/Info

Title:
-
作者:
沈迎; 张瑞岩; 丁风华; 沈卫峰
200025 上海交通大学医学院附属瑞金医院心脏科
Author(s):
-
关键词:
冠状动脉粥样硬化性心脏病; 微循环; 糖尿病; 心绞痛
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.05.001
文献标识码:
-
摘要:
临床上,冠状动脉微血管性心绞痛(coronarymicrovascularangina,CMVA)十分常见,但其发生机制尚未完全清楚,有效的治疗方法还在探索中。糖尿病患者除了常存在严重(多支)和弥漫性心外膜冠状动脉病变外,冠状动脉微血管功能异常(coronarymicrovasculardysfunction,CMVD)也相当常见,后者参与糖尿病心肌病和CMVA的发生和发展。因此,进一步深入开展糖尿病CMVD和CMVA的研究,对这些患者的诊治和预后评估具有重要的临床价值。
Abstract:
-

参考文献/References

[1] Camici PG, d'Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment[J]. Nat Rev Cardiol,2015,12(1):48-62.
[2] Dean J, Cruz SD, Mehta PK, et al. Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy[J]. Nat Rev Cardiol,2015,12(7):406-414
[3] Seferovic PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes[J]. Eur Heart J, 2015,36(27):1718-1727,
[4] 赵 航,冯景辉,吴秀萍. 糖尿病心肌病发病机制的研究进展[J]. 国际心血管病杂志,2016,43(1):16-18.
[5] Picchi A, Capobianco S, Qiu T, et al. Coronary microvascular dysfunction in diabetes mellitus: A review[J]. World J Cardiol,2010,2(11):377-390.
[6] Crea F, Camici PG, Merz CN. Coronary microvascular dysfunction: an update[J]. Eur Heart J, 2014,35(17):1101-1111.
[7] Titterington JS, Hung OY, Wenger N. Microvascular angina: an update on diagnosis and treatment[J]. Future Cardiol, 2015,11(2):229-242.
[8] Jespersen L, Hvelplund A, Abildstrom SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events[J]. Eur Heart J, 2012,33(6):734-744.
[9] Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J]. J Am Coll Cardiol,2014,64(18):1929-1949
[10] Suzuki H. Different definition of microvascular angina[J]. Eur J Clin Incest, 2015,45(12):1360-1366.
[11] Camici PG, Crea F. Coronary microvascular dysfunction[J]. N Engl J Med,2007,356(8):830-840.
[12] Selthofer-Relatic' K, Bonjak I, Kibel A.Obesity related coronary microvascular dysfunction: From basic to clinical practice[J].Cardiol Res Pract,2016,2016:8173816.
[13] Nahser PJ Jr, Brown RE, Oskarsson H, et al. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus[J]. Circulation,1995, 91(3):635-640.
[14] von Scholten BJ, Hasbak P, Christensen TE, et al Cardiac(82)Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes[J]. Diabetologia, 2016,59(2):371-378.
[15] Leung M, Leung DY. Coronary microvascular function in patients with type 2 diabetes mellitus[J]. EuroIntervention,2016,11(10):1111-1117.
[16] Loffler AI, Bourque JM. Coronary microvascular dysfunction, microvascular angina, and management[J]. Curr Cardiol Rep,2016,18(1):1-7.
[17] 范永臻,黄 河,吴名星,等. 尼可地尔对稳定型心绞痛患者PCI术后冠状动脉微循环阻力指数的影响[J]. 国际心血管病杂志,2015,42(6):412-415.
[18] Tagliamonte E, Rigo F, Cirillo T, et al. Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease[J]. Echocardiography,2015,32(3):516-521.
[19] Merz CN, Handberg EM, Shufelt CL, et al. A randomized, placebo-controlled trial of late Na current inhibition(ranolazine)in coronary microvascular dysfunction(CMD): impact on angina and myocardial perfusion reserve[J].Eur Heart J,2016,37(19):1504-1513.
[20] Lamendola P, Lanza GA, Spinelli A, et al. Lonf-term prognosis of patients with cardiac syndrome X [J]. Int J Cardiol, 2010,140(2):197-199.
[21] Crea F, Lanza GA. Treatment of microvascular angina.The need for precision medicine[J]. Eur Heart J,2016, 37(19):1514-1516.

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金(81400327); 上海市科委基金项目(14ZR1425800) 作者单位:200025 上海交通大学医学院附属瑞金医院心脏科 通信作者: 沈卫峰,Email: rjshenweifeng@126.com
更新日期/Last Update: 2016-09-20